ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,324Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 131

$3.37M Total Retail Price of All Prescriptions

Rank: 3 out of 131

735 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

32% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

5% of this provider’s 3,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$326 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,580 566 S3 1 1
GABAPENTIN 370 133 2 3
TIZANIDINE HCL 345 106 3 47
CARISOPRODOL 279 76 R 4 57
CARBAMAZEPINE 277 98 5 101
MORPHINE SULFATE ER 265 37 S2 6 104
LEVETIRACETAM 263 80 7 68
HYDROMORPHONE HCL 221 22 S2 8 164
LYRICA 216 62 9 79
NAMENDA 212 204 10 31
ZOLPIDEM TARTRATE 197 70 11 12
METHADONE HCL 180 13 S2 12 182
TOPIRAMATE 176 39 13 55
FENTANYL 176 37 S2 13 88
OXYCODONE HCL 174 54 S2 15 128
PRIMIDONE 168 102 16 110
OXYCONTIN 146 38 S2 17 206
DONEPEZIL HCL 141 123 18 10
CYCLOBENZAPRINE HCL 140 19 R 19 43
AMITRIPTYLINE HCL 137 64 R 20 64
CITALOPRAM HBR 123 50 21 29
BACLOFEN 117 15 22 84
OXCARBAZEPINE 116 36 23 169
OXYCODONE HCL-ACETAMINOPHEN 115 44 S2 24 153
AMPHETAMINE SALT COMBO 115 0 S2 24 236
METHYLPHENIDATE HCL 112 36 26 240
DIVALPROEX SODIUM ER 111 0 27 159
TRAMADOL HCL 110 38 28 17
DIVALPROEX SODIUM 103 26 29 134
CARBIDOPA-LEVODOPA 95 47 30 50
CYMBALTA 94 20 31 51
SUMATRIPTAN SUCCINATE 91 11 32 144
PHENYTOIN SODIUM EXTENDED 91 43 32 76
TRAZODONE HCL 90 33 34 80
ENDOCET 85 22 S2 35 126
ESCITALOPRAM OXALATE 79 48 36 92
GAMMAGARD LIQUID 79 46 36 272
DOXEPIN HCL 75 27 38 276
VIMPAT 75 25 38 217
SERTRALINE HCL 69 29 40 44
MORPHINE SULFATE 69 16 S2 40 292
LAMOTRIGINE 68 22 42 150
ALENDRONATE SODIUM 65 0 43 78
ROPINIROLE HCL 64 15 44 83
PAROXETINE HCL 62 13 45 93
PRAMIPEXOLE DIHYDROCHLORIDE 61 23 46 141
COPAXONE 59 12 47 111
REBIF 54 0 48 182
VENLAFAXINE HCL ER 52 32 49 218
ACETAMINOPHEN-CODEINE 51 0 S3 50 336
GALANTAMINE HBR 50 47 51 219
AVONEX 50 12 51 188
PYRIDOSTIGMINE BROMIDE 50 27 51 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.